Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 28, 2017

DrugPatentWatch Database Preview

SERTRALINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Sertraline Hydrochloride, and when can generics launch?

Sertraline Hydrochloride is a drug marketed by Wockhardt, Aurobindo Pharma, Zydus Pharms Usa, Sun Pharm Inds (in), Sandoz, Frontida Biopharm, Ivax Sub Teva Pharms, Accord Hlthcare, Mylan Pharms Inc, Allied Pharma Inc, Dr Reddys Labs Ltd, Actavis Elizabeth, Ranbaxy Labs Ltd, Cipla Ltd, Watson Labs, Hikma Pharms, Teva, Torrent Pharms, Lupin, Mylan, Oxford Pharms, Austarpharma Llc, Sun Pharm Inds Ltd, Apotex Inc, Invagen Pharms, and Pliva Hrvatska Doo. and is included in twenty-nine NDAs.

The generic ingredient in SERTRALINE HYDROCHLORIDE is sertraline hydrochloride. There are twenty-two drug master file entries for this compound. Sixty-one suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the sertraline hydrochloride profile page.

Summary for Tradename: SERTRALINE HYDROCHLORIDE

Patents:0
Applicants:26
NDAs:29
Suppliers / Packagers: see list54
Bulk Api Vendors: see list68
Clinical Trials: see list1,090
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SERTRALINE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: SERTRALINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allied Pharma Inc
SERTRALINE HYDROCHLORIDE
sertraline hydrochloride
TABLET;ORAL076881-001Feb 6, 2007DISCNNoNo► Subscribe► Subscribe
Cipla Ltd
SERTRALINE HYDROCHLORIDE
sertraline hydrochloride
TABLET;ORAL077162-002Feb 6, 2007DISCNNoNo► Subscribe► Subscribe
Dr Reddys Labs Ltd
SERTRALINE HYDROCHLORIDE
sertraline hydrochloride
TABLET;ORAL076442-001Apr 30, 2007DISCNNoNo► Subscribe► Subscribe
Teva
SERTRALINE HYDROCHLORIDE
sertraline hydrochloride
TABLET;ORAL076465-001Aug 11, 2006ABRXNoNo► Subscribe► Subscribe
Mylan
SERTRALINE HYDROCHLORIDE
sertraline hydrochloride
TABLET;ORAL076671-003Feb 6, 2007DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Formulary management
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot